nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—ACSL4—Rosiglitazone—type 2 diabetes mellitus	0.225	0.429	CbGbCtD
Icosapent—PPARG—type 2 diabetes mellitus	0.17	0.703	CbGaD
Icosapent—PTGS2—type 2 diabetes mellitus	0.0717	0.297	CbGaD
Icosapent—PPARG—Glipizide—type 2 diabetes mellitus	0.0615	0.117	CbGbCtD
Icosapent—PPARG—Repaglinide—type 2 diabetes mellitus	0.0538	0.102	CbGbCtD
Icosapent—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0486	0.0927	CbGbCtD
Icosapent—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0449	0.0855	CbGbCtD
Icosapent—PPARG—Nateglinide—type 2 diabetes mellitus	0.0369	0.0702	CbGbCtD
Icosapent—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0123	0.0234	CbGbCtD
Icosapent—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0123	0.0234	CbGbCtD
Icosapent—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0216	CbGbCtD
Icosapent—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00929	0.0177	CbGbCtD
Icosapent—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00891	0.017	CbGbCtD
Icosapent—TRPV1—sciatic nerve—type 2 diabetes mellitus	0.00782	0.135	CbGeAlD
Icosapent—FFAR1—islet of Langerhans—type 2 diabetes mellitus	0.00514	0.0887	CbGeAlD
Icosapent—FFAR1—pancreas—type 2 diabetes mellitus	0.00362	0.0623	CbGeAlD
Icosapent—TRPV1—peripheral nervous system—type 2 diabetes mellitus	0.003	0.0517	CbGeAlD
Icosapent—TRPV1—nerve—type 2 diabetes mellitus	0.00234	0.0403	CbGeAlD
Icosapent—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.00219	0.0377	CbGeAlD
Icosapent—PPARG—leg—type 2 diabetes mellitus	0.00176	0.0303	CbGeAlD
Icosapent—PPARG—hindlimb—type 2 diabetes mellitus	0.00157	0.0271	CbGeAlD
Icosapent—ACSL3—cardiovascular system—type 2 diabetes mellitus	0.00148	0.0255	CbGeAlD
Icosapent—ACSL3—pancreas—type 2 diabetes mellitus	0.00144	0.0248	CbGeAlD
Icosapent—SLC8A1—cardiovascular system—type 2 diabetes mellitus	0.00123	0.0212	CbGeAlD
Icosapent—SLC8A1—kidney—type 2 diabetes mellitus	0.0012	0.0207	CbGeAlD
Icosapent—FADS1—islet of Langerhans—type 2 diabetes mellitus	0.00113	0.0195	CbGeAlD
Icosapent—FABP7—retina—type 2 diabetes mellitus	0.00107	0.0184	CbGeAlD
Icosapent—ACSL4—islet of Langerhans—type 2 diabetes mellitus	0.00103	0.0177	CbGeAlD
Icosapent—PPARD—islet of Langerhans—type 2 diabetes mellitus	0.000987	0.017	CbGeAlD
Icosapent—FADS1—retina—type 2 diabetes mellitus	0.000968	0.0167	CbGeAlD
Icosapent—PPARG—artery—type 2 diabetes mellitus	0.000963	0.0166	CbGeAlD
Icosapent—ACSL3—liver—type 2 diabetes mellitus	0.000916	0.0158	CbGeAlD
Icosapent—PTGS2—leg—type 2 diabetes mellitus	0.000898	0.0155	CbGeAlD
Icosapent—ACSL4—retina—type 2 diabetes mellitus	0.000879	0.0151	CbGeAlD
Icosapent—ACSL4—nephron tubule—type 2 diabetes mellitus	0.000828	0.0143	CbGeAlD
Icosapent—PPARG—endothelium—type 2 diabetes mellitus	0.000813	0.014	CbGeAlD
Icosapent—PTGS2—hindlimb—type 2 diabetes mellitus	0.000802	0.0138	CbGeAlD
Icosapent—FADS1—pancreas—type 2 diabetes mellitus	0.000796	0.0137	CbGeAlD
Icosapent—TRPV1—pancreas—type 2 diabetes mellitus	0.000796	0.0137	CbGeAlD
Icosapent—FADS1—cortex of kidney—type 2 diabetes mellitus	0.00078	0.0134	CbGeAlD
Icosapent—Malnutrition—Linagliptin—type 2 diabetes mellitus	0.000774	0.0125	CcSEcCtD
Icosapent—ACSL4—cardiovascular system—type 2 diabetes mellitus	0.000744	0.0128	CbGeAlD
Icosapent—Eructation—Orlistat—type 2 diabetes mellitus	0.000732	0.0119	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Pioglitazone—type 2 diabetes mellitus	0.000728	0.0118	CcSEcCtD
Icosapent—Malnutrition—Nateglinide—type 2 diabetes mellitus	0.000725	0.0117	CcSEcCtD
Icosapent—ACSL4—pancreas—type 2 diabetes mellitus	0.000723	0.0125	CbGeAlD
Icosapent—FADS1—adipose tissue—type 2 diabetes mellitus	0.000722	0.0124	CbGeAlD
Icosapent—Alanine aminotransferase increased—Glimepiride—type 2 diabetes mellitus	0.000709	0.0115	CcSEcCtD
Icosapent—ACSL4—cortex of kidney—type 2 diabetes mellitus	0.000709	0.0122	CbGeAlD
Icosapent—PPARD—pancreas—type 2 diabetes mellitus	0.000694	0.012	CbGeAlD
Icosapent—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.000674	0.0109	CcSEcCtD
Icosapent—Constipation—Miglitol—type 2 diabetes mellitus	0.000668	0.0108	CcSEcCtD
Icosapent—Arthralgia—Linagliptin—type 2 diabetes mellitus	0.000659	0.0107	CcSEcCtD
Icosapent—ACSL4—adipose tissue—type 2 diabetes mellitus	0.000656	0.0113	CbGeAlD
Icosapent—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000632	0.0102	CcSEcCtD
Icosapent—PPARD—adipose tissue—type 2 diabetes mellitus	0.00063	0.0108	CbGeAlD
Icosapent—Malnutrition—Repaglinide—type 2 diabetes mellitus	0.000627	0.0102	CcSEcCtD
Icosapent—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.000618	0.01	CcSEcCtD
Icosapent—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.000606	0.00982	CcSEcCtD
Icosapent—Malnutrition—Rosiglitazone—type 2 diabetes mellitus	0.000593	0.00961	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Linagliptin—type 2 diabetes mellitus	0.000576	0.00933	CcSEcCtD
Icosapent—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.000562	0.00911	CcSEcCtD
Icosapent—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.000562	0.00911	CcSEcCtD
Icosapent—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.000551	0.00893	CcSEcCtD
Icosapent—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.000551	0.00893	CcSEcCtD
Icosapent—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.000546	0.00884	CcSEcCtD
Icosapent—Constipation—Linagliptin—type 2 diabetes mellitus	0.00054	0.00875	CcSEcCtD
Icosapent—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.00054	0.00875	CcSEcCtD
Icosapent—Arthralgia—Repaglinide—type 2 diabetes mellitus	0.000534	0.00865	CcSEcCtD
Icosapent—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00053	0.00858	CcSEcCtD
Icosapent—Constipation—Acarbose—type 2 diabetes mellitus	0.000525	0.0085	CcSEcCtD
Icosapent—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.000521	0.00844	CcSEcCtD
Icosapent—PTGS1—artery—type 2 diabetes mellitus	0.000515	0.00887	CbGeAlD
Icosapent—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000512	0.00829	CcSEcCtD
Icosapent—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.000511	0.00827	CcSEcCtD
Icosapent—FADS1—liver—type 2 diabetes mellitus	0.000506	0.00873	CbGeAlD
Icosapent—Arthralgia—Rosiglitazone—type 2 diabetes mellitus	0.000505	0.00818	CcSEcCtD
Icosapent—Malnutrition—Pioglitazone—type 2 diabetes mellitus	0.000497	0.00806	CcSEcCtD
Icosapent—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000497	0.00804	CcSEcCtD
Icosapent—Rash—Miglitol—type 2 diabetes mellitus	0.000492	0.00797	CcSEcCtD
Icosapent—PTGS2—artery—type 2 diabetes mellitus	0.000492	0.00848	CbGeAlD
Icosapent—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000492	0.00797	CcSEcCtD
Icosapent—Malnutrition—Glimepiride—type 2 diabetes mellitus	0.000484	0.00785	CcSEcCtD
Icosapent—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000484	0.00784	CcSEcCtD
Icosapent—Malnutrition—Sitagliptin—type 2 diabetes mellitus	0.000483	0.00782	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.000467	0.00756	CcSEcCtD
Icosapent—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000463	0.00797	CbGeAlD
Icosapent—ACSL4—liver—type 2 diabetes mellitus	0.00046	0.00793	CbGeAlD
Icosapent—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000452	0.00732	CcSEcCtD
Icosapent—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000452	0.00732	CcSEcCtD
Icosapent—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.000451	0.0073	CcSEcCtD
Icosapent—Rash—Tolbutamide—type 2 diabetes mellitus	0.000443	0.00717	CcSEcCtD
Icosapent—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000442	0.00716	CcSEcCtD
Icosapent—Arthralgia—Glipizide—type 2 diabetes mellitus	0.000442	0.00716	CcSEcCtD
Icosapent—PPARD—liver—type 2 diabetes mellitus	0.000441	0.00761	CbGeAlD
Icosapent—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000441	0.00714	CcSEcCtD
Icosapent—Constipation—Repaglinide—type 2 diabetes mellitus	0.000438	0.00709	CcSEcCtD
Icosapent—PTGS1—endothelium—type 2 diabetes mellitus	0.000435	0.00749	CbGeAlD
Icosapent—Dysgeusia—Bromocriptine—type 2 diabetes mellitus	0.000428	0.00693	CcSEcCtD
Icosapent—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.000423	0.00686	CcSEcCtD
Icosapent—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000419	0.00678	CcSEcCtD
Icosapent—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000418	0.00677	CcSEcCtD
Icosapent—PTGS2—endothelium—type 2 diabetes mellitus	0.000415	0.00716	CbGeAlD
Icosapent—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000414	0.0067	CcSEcCtD
Icosapent—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000411	0.00666	CcSEcCtD
Icosapent—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000406	0.00658	CcSEcCtD
Icosapent—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000406	0.00657	CcSEcCtD
Icosapent—Rash—Tolazamide—type 2 diabetes mellitus	0.000403	0.00652	CcSEcCtD
Icosapent—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000403	0.00652	CcSEcCtD
Icosapent—Malnutrition—Glyburide—type 2 diabetes mellitus	0.000399	0.00647	CcSEcCtD
Icosapent—Rash—Linagliptin—type 2 diabetes mellitus	0.000398	0.00645	CcSEcCtD
Icosapent—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000398	0.00645	CcSEcCtD
Icosapent—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000395	0.0064	CcSEcCtD
Icosapent—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000394	0.00638	CcSEcCtD
Icosapent—Vomiting—Acarbose—type 2 diabetes mellitus	0.00039	0.00632	CcSEcCtD
Icosapent—Rash—Acarbose—type 2 diabetes mellitus	0.000387	0.00627	CcSEcCtD
Icosapent—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000386	0.00626	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000386	0.00625	CcSEcCtD
Icosapent—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000376	0.00609	CcSEcCtD
Icosapent—Rash—Nateglinide—type 2 diabetes mellitus	0.000373	0.00604	CcSEcCtD
Icosapent—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000373	0.00604	CcSEcCtD
Icosapent—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000373	0.00604	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00037	0.00599	CcSEcCtD
Icosapent—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000366	0.00592	CcSEcCtD
Icosapent—Constipation—Glipizide—type 2 diabetes mellitus	0.000362	0.00587	CcSEcCtD
Icosapent—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000362	0.00587	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000359	0.00582	CcSEcCtD
Icosapent—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000359	0.00581	CcSEcCtD
Icosapent—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00035	0.00568	CcSEcCtD
Icosapent—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000348	0.00564	CcSEcCtD
Icosapent—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00562	CcSEcCtD
Icosapent—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000342	0.00555	CcSEcCtD
Icosapent—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000341	0.00553	CcSEcCtD
Icosapent—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00034	0.00551	CcSEcCtD
Icosapent—Arthralgia—Glyburide—type 2 diabetes mellitus	0.00034	0.00551	CcSEcCtD
Icosapent—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000337	0.00546	CcSEcCtD
Icosapent—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000335	0.00577	CbGeAlD
Icosapent—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00033	0.00534	CcSEcCtD
Icosapent—PPARG—kidney—type 2 diabetes mellitus	0.000327	0.00564	CbGeAlD
Icosapent—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000326	0.00528	CcSEcCtD
Icosapent—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000326	0.00527	CcSEcCtD
Icosapent—PPARG—pancreas—type 2 diabetes mellitus	0.000325	0.0056	CbGeAlD
Icosapent—Rash—Repaglinide—type 2 diabetes mellitus	0.000323	0.00523	CcSEcCtD
Icosapent—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000323	0.00523	CcSEcCtD
Icosapent—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000323	0.00523	CcSEcCtD
Icosapent—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000319	0.00517	CcSEcCtD
Icosapent—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00509	CcSEcCtD
Icosapent—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00499	CcSEcCtD
Icosapent—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000305	0.00495	CcSEcCtD
Icosapent—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00494	CcSEcCtD
Icosapent—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000305	0.00494	CcSEcCtD
Icosapent—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000305	0.00494	CcSEcCtD
Icosapent—Malnutrition—Metformin—type 2 diabetes mellitus	0.0003	0.00486	CcSEcCtD
Icosapent—Pruritus—Glipizide—type 2 diabetes mellitus	0.0003	0.00486	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000297	0.00481	CcSEcCtD
Icosapent—PPARG—adipose tissue—type 2 diabetes mellitus	0.000295	0.00508	CbGeAlD
Icosapent—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000294	0.00476	CcSEcCtD
Icosapent—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000287	0.00465	CcSEcCtD
Icosapent—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000283	0.00459	CcSEcCtD
Icosapent—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000281	0.00456	CcSEcCtD
Icosapent—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000281	0.00455	CcSEcCtD
Icosapent—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00028	0.00453	CcSEcCtD
Icosapent—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000277	0.00449	CcSEcCtD
Icosapent—Vomiting—Glipizide—type 2 diabetes mellitus	0.000269	0.00436	CcSEcCtD
Icosapent—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000269	0.00436	CcSEcCtD
Icosapent—Rash—Glipizide—type 2 diabetes mellitus	0.000267	0.00433	CcSEcCtD
Icosapent—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000267	0.00432	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000267	0.00432	CcSEcCtD
Icosapent—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000266	0.00431	CcSEcCtD
Icosapent—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000261	0.00423	CcSEcCtD
Icosapent—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000258	0.00417	CcSEcCtD
Icosapent—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000253	0.00409	CcSEcCtD
Icosapent—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000251	0.00407	CcSEcCtD
Icosapent—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00406	CcSEcCtD
Icosapent—Constipation—Gliclazide—type 2 diabetes mellitus	0.00025	0.00406	CcSEcCtD
Icosapent—Rash—Glimepiride—type 2 diabetes mellitus	0.000249	0.00404	CcSEcCtD
Icosapent—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000249	0.00403	CcSEcCtD
Icosapent—Rash—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00403	CcSEcCtD
Icosapent—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00402	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000245	0.00397	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000242	0.00392	CcSEcCtD
Icosapent—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000241	0.00391	CcSEcCtD
Icosapent—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000237	0.00384	CcSEcCtD
Icosapent—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000236	0.00407	CbGeAlD
Icosapent—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000234	0.00379	CcSEcCtD
Icosapent—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000232	0.00376	CcSEcCtD
Icosapent—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000231	0.00374	CcSEcCtD
Icosapent—Pruritus—Glyburide—type 2 diabetes mellitus	0.000231	0.00374	CcSEcCtD
Icosapent—Constipation—Valsartan—type 2 diabetes mellitus	0.00023	0.00373	CcSEcCtD
Icosapent—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000229	0.00372	CcSEcCtD
Icosapent—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000229	0.0037	CcSEcCtD
Icosapent—Arthralgia—Losartan—type 2 diabetes mellitus	0.000227	0.00368	CcSEcCtD
Icosapent—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00367	CcSEcCtD
Icosapent—Rash—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00364	CcSEcCtD
Icosapent—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00364	CcSEcCtD
Icosapent—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000224	0.00363	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000223	0.00362	CcSEcCtD
Icosapent—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000218	0.00352	CcSEcCtD
Icosapent—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000216	0.00349	CcSEcCtD
Icosapent—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000211	0.00343	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000211	0.00341	CcSEcCtD
Icosapent—Constipation—Metformin—type 2 diabetes mellitus	0.000209	0.00339	CcSEcCtD
Icosapent—Vomiting—Glyburide—type 2 diabetes mellitus	0.000207	0.00336	CcSEcCtD
Icosapent—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000207	0.00336	CcSEcCtD
Icosapent—PPARG—liver—type 2 diabetes mellitus	0.000207	0.00357	CbGeAlD
Icosapent—Rash—Glyburide—type 2 diabetes mellitus	0.000206	0.00333	CcSEcCtD
Icosapent—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000205	0.00333	CcSEcCtD
Icosapent—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000203	0.0033	CcSEcCtD
Icosapent—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.0002	0.00323	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000198	0.00321	CcSEcCtD
Icosapent—Constipation—Irbesartan—type 2 diabetes mellitus	0.000198	0.0032	CcSEcCtD
Icosapent—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000195	0.00315	CcSEcCtD
Icosapent—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000191	0.0031	CcSEcCtD
Icosapent—Pruritus—Valsartan—type 2 diabetes mellitus	0.00019	0.00308	CcSEcCtD
Icosapent—Pruritus—Orlistat—type 2 diabetes mellitus	0.000188	0.00305	CcSEcCtD
Icosapent—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000187	0.00302	CcSEcCtD
Icosapent—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000186	0.00302	CcSEcCtD
Icosapent—Constipation—Losartan—type 2 diabetes mellitus	0.000186	0.00301	CcSEcCtD
Icosapent—Rash—Gliclazide—type 2 diabetes mellitus	0.000185	0.00299	CcSEcCtD
Icosapent—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000184	0.00299	CcSEcCtD
Icosapent—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000179	0.00308	CbGeAlD
Icosapent—PTGS1—kidney—type 2 diabetes mellitus	0.000175	0.00302	CbGeAlD
Icosapent—Pruritus—Metformin—type 2 diabetes mellitus	0.000173	0.00281	CcSEcCtD
Icosapent—Vomiting—Valsartan—type 2 diabetes mellitus	0.000171	0.00277	CcSEcCtD
Icosapent—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000171	0.00295	CbGeAlD
Icosapent—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00017	0.00275	CcSEcCtD
Icosapent—Rash—Valsartan—type 2 diabetes mellitus	0.00017	0.00275	CcSEcCtD
Icosapent—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000169	0.00274	CcSEcCtD
Icosapent—Vomiting—Orlistat—type 2 diabetes mellitus	0.000169	0.00274	CcSEcCtD
Icosapent—Rash—Orlistat—type 2 diabetes mellitus	0.000168	0.00271	CcSEcCtD
Icosapent—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000167	0.00271	CcSEcCtD
Icosapent—PTGS2—kidney—type 2 diabetes mellitus	0.000167	0.00288	CbGeAlD
Icosapent—PTGS2—pancreas—type 2 diabetes mellitus	0.000166	0.00286	CbGeAlD
Icosapent—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000164	0.00266	CcSEcCtD
Icosapent—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000164	0.00265	CcSEcCtD
Icosapent—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000161	0.00261	CcSEcCtD
Icosapent—Constipation—Ramipril—type 2 diabetes mellitus	0.00016	0.00258	CcSEcCtD
Icosapent—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000158	0.00272	CbGeAlD
Icosapent—Vomiting—Metformin—type 2 diabetes mellitus	0.000156	0.00252	CcSEcCtD
Icosapent—Rash—Metformin—type 2 diabetes mellitus	0.000154	0.0025	CcSEcCtD
Icosapent—Dermatitis—Metformin—type 2 diabetes mellitus	0.000154	0.0025	CcSEcCtD
Icosapent—Pruritus—Losartan—type 2 diabetes mellitus	0.000154	0.00249	CcSEcCtD
Icosapent—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000151	0.0026	CbGeAlD
Icosapent—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000147	0.00238	CcSEcCtD
Icosapent—Rash—Irbesartan—type 2 diabetes mellitus	0.000146	0.00236	CcSEcCtD
Icosapent—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000146	0.00236	CcSEcCtD
Icosapent—Vomiting—Losartan—type 2 diabetes mellitus	0.000138	0.00224	CcSEcCtD
Icosapent—Rash—Losartan—type 2 diabetes mellitus	0.000137	0.00222	CcSEcCtD
Icosapent—Dermatitis—Losartan—type 2 diabetes mellitus	0.000137	0.00222	CcSEcCtD
Icosapent—Pruritus—Ramipril—type 2 diabetes mellitus	0.000132	0.00214	CcSEcCtD
Icosapent—Vomiting—Ramipril—type 2 diabetes mellitus	0.000119	0.00192	CcSEcCtD
Icosapent—Rash—Ramipril—type 2 diabetes mellitus	0.000118	0.00191	CcSEcCtD
Icosapent—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000118	0.0019	CcSEcCtD
Icosapent—PTGS2—liver—type 2 diabetes mellitus	0.000106	0.00182	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—type 2 diabetes mellitus	8.97e-05	1	CrCbGaD
Icosapent—PPARG—Metabolism—CTGF—type 2 diabetes mellitus	4.86e-06	4.26e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HMGCR—type 2 diabetes mellitus	4.82e-06	4.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HK1—type 2 diabetes mellitus	4.78e-06	4.19e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.75e-06	4.17e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADRA2A—type 2 diabetes mellitus	4.71e-06	4.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	4.71e-06	4.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	4.71e-06	4.13e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4.68e-06	4.1e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	4.68e-06	4.1e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALDOB—type 2 diabetes mellitus	4.67e-06	4.09e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.65e-06	4.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	4.63e-06	4.06e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-06	4.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	4.62e-06	4.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.62e-06	4.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—GCKR—type 2 diabetes mellitus	4.61e-06	4.05e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SIRT1—type 2 diabetes mellitus	4.6e-06	4.04e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.58e-06	4.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.56e-06	4e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	4.53e-06	3.98e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP2E1—type 2 diabetes mellitus	4.53e-06	3.97e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PPARG—type 2 diabetes mellitus	4.5e-06	3.95e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.49e-06	3.93e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SLC2A1—type 2 diabetes mellitus	4.48e-06	3.93e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP1A2—type 2 diabetes mellitus	4.48e-06	3.93e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.44e-06	3.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	4.42e-06	3.88e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—INS—type 2 diabetes mellitus	4.42e-06	3.87e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.41e-06	3.86e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.39e-06	3.85e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP3A4—type 2 diabetes mellitus	4.37e-06	3.83e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.34e-06	3.81e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GLP1R—type 2 diabetes mellitus	4.34e-06	3.8e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SLC2A4—type 2 diabetes mellitus	4.29e-06	3.76e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GCG—type 2 diabetes mellitus	4.29e-06	3.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	4.27e-06	3.75e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—type 2 diabetes mellitus	4.27e-06	3.74e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-06	3.74e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NFKB1—type 2 diabetes mellitus	4.22e-06	3.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	4.22e-06	3.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.21e-06	3.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.18e-06	3.67e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—type 2 diabetes mellitus	4.18e-06	3.67e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-06	3.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RBP4—type 2 diabetes mellitus	4.11e-06	3.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.1e-06	3.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	4.1e-06	3.6e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NR3C1—type 2 diabetes mellitus	4.08e-06	3.58e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PPP2CA—type 2 diabetes mellitus	4.07e-06	3.56e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—type 2 diabetes mellitus	4.05e-06	3.55e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.05e-06	3.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	4e-06	3.51e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	4e-06	3.5e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	3.97e-06	3.48e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	3.97e-06	3.48e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SRC—type 2 diabetes mellitus	3.93e-06	3.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.91e-06	3.43e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	3.89e-06	3.41e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NOS3—type 2 diabetes mellitus	3.87e-06	3.4e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3R1—type 2 diabetes mellitus	3.87e-06	3.4e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.87e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	3.87e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	3.87e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	3.87e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	3.86e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	3.86e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	3.86e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	3.86e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.84e-06	3.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	3.84e-06	3.37e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—type 2 diabetes mellitus	3.83e-06	3.36e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PPARA—type 2 diabetes mellitus	3.83e-06	3.36e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.81e-06	3.34e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.77e-06	3.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTR—type 2 diabetes mellitus	3.76e-06	3.3e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.74e-06	3.28e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	3.73e-06	3.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.72e-06	3.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	3.7e-06	3.25e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.7e-06	3.24e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GNB3—type 2 diabetes mellitus	3.7e-06	3.24e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	3.69e-06	3.23e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HMOX1—type 2 diabetes mellitus	3.68e-06	3.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—GCK—type 2 diabetes mellitus	3.67e-06	3.21e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IAPP—type 2 diabetes mellitus	3.64e-06	3.19e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CAT—type 2 diabetes mellitus	3.63e-06	3.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.6e-06	3.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	3.58e-06	3.14e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—type 2 diabetes mellitus	3.54e-06	3.11e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOB—type 2 diabetes mellitus	3.53e-06	3.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.53e-06	3.09e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TGFB1—type 2 diabetes mellitus	3.52e-06	3.08e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—type 2 diabetes mellitus	3.5e-06	3.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.49e-06	3.06e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.48e-06	3.05e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	3.47e-06	3.04e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	3.47e-06	3.04e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	3.47e-06	3.04e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—type 2 diabetes mellitus	3.45e-06	3.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	3.44e-06	3.02e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTM1—type 2 diabetes mellitus	3.43e-06	3.01e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	3.4e-06	2.99e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	3.37e-06	2.96e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—LPL—type 2 diabetes mellitus	3.37e-06	2.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	3.35e-06	2.94e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.33e-06	2.92e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.3e-06	2.9e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	2.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	3.29e-06	2.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	3.29e-06	2.88e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GPX1—type 2 diabetes mellitus	3.29e-06	2.88e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—type 2 diabetes mellitus	3.28e-06	2.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.22e-06	2.82e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CD36—type 2 diabetes mellitus	3.2e-06	2.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CYBA—type 2 diabetes mellitus	3.18e-06	2.79e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.17e-06	2.78e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-06	2.78e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-06	2.78e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPP2CA—type 2 diabetes mellitus	3.16e-06	2.77e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	3.15e-06	2.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	3.15e-06	2.76e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.14e-06	2.75e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.14e-06	2.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	3.09e-06	2.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CALCA—type 2 diabetes mellitus	3.08e-06	2.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.07e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	3.07e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	3.07e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	3.07e-06	2.69e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.06e-06	2.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.05e-06	2.68e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.04e-06	2.67e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—type 2 diabetes mellitus	3.03e-06	2.66e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.01e-06	2.64e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	3.01e-06	2.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	3e-06	2.63e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	2.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	2.97e-06	2.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	2.96e-06	2.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS1—type 2 diabetes mellitus	2.93e-06	2.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.91e-06	2.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	2.9e-06	2.54e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AGT—type 2 diabetes mellitus	2.88e-06	2.53e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-06	2.52e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	2.85e-06	2.5e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.85e-06	2.5e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CALM1—type 2 diabetes mellitus	2.83e-06	2.48e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOE—type 2 diabetes mellitus	2.82e-06	2.48e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOA1—type 2 diabetes mellitus	2.79e-06	2.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.76e-06	2.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	2.75e-06	2.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	2.75e-06	2.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	2.75e-06	2.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	2.7e-06	2.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	2.68e-06	2.35e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—type 2 diabetes mellitus	2.65e-06	2.32e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-06	2.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.64e-06	2.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.62e-06	2.3e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	2.59e-06	2.27e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.59e-06	2.27e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	2.58e-06	2.26e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	2.55e-06	2.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.52e-06	2.21e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.49e-06	2.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.49e-06	2.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	2.48e-06	2.17e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	2.47e-06	2.17e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—type 2 diabetes mellitus	2.45e-06	2.14e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.43e-06	2.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—INS—type 2 diabetes mellitus	2.41e-06	2.12e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-06	2.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	2.4e-06	2.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.39e-06	2.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	2.39e-06	2.09e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	2.36e-06	2.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOB—type 2 diabetes mellitus	2.34e-06	2.05e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-06	2.03e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	2.3e-06	2.02e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—type 2 diabetes mellitus	2.29e-06	2.01e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	2.24e-06	1.97e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—LPL—type 2 diabetes mellitus	2.24e-06	1.96e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-06	1.94e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—type 2 diabetes mellitus	2.21e-06	1.94e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	2.19e-06	1.92e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-06	1.86e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	1.86e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	1.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	2.1e-06	1.84e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-06	1.83e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.06e-06	1.81e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.06e-06	1.8e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.06e-06	1.8e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.05e-06	1.8e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.02e-06	1.77e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	2.02e-06	1.77e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.01e-06	1.77e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.99e-06	1.74e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.98e-06	1.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.96e-06	1.72e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.96e-06	1.71e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-06	1.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.92e-06	1.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.92e-06	1.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.91e-06	1.67e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.88e-06	1.65e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.88e-06	1.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.87e-06	1.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.85e-06	1.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.83e-06	1.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.83e-06	1.6e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-06	1.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.78e-06	1.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.76e-06	1.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.75e-06	1.53e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	1.51e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	1.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	1.69e-06	1.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IRS1—type 2 diabetes mellitus	1.67e-06	1.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	1.65e-06	1.45e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	1.6e-06	1.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—INS—type 2 diabetes mellitus	1.6e-06	1.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-06	1.38e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	1.57e-06	1.38e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	1.55e-06	1.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	1.36e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT2—type 2 diabetes mellitus	1.55e-06	1.36e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.3e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	1.47e-06	1.29e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.4e-06	1.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.4e-06	1.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.37e-06	1.2e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	1.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.34e-06	1.18e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	1.25e-06	1.1e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.23e-06	1.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-06	1.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.04e-06	9.11e-06	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	9.72e-07	8.53e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	9.29e-07	8.15e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—type 2 diabetes mellitus	9.11e-07	7.99e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—type 2 diabetes mellitus	7e-07	6.14e-06	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	6.81e-07	5.97e-06	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—type 2 diabetes mellitus	6.46e-07	5.66e-06	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	5.41e-07	4.74e-06	CbGpPWpGaD
